Compare Danaher Corporation (DHR) vs Vanguard Total World Stock Index Fund ETF (VT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Vanguard Total World Stock Index Fund ETF — how do they compare? Danaher Corporation trades at $198.81 (market cap $140.88B), while Vanguard Total World Stock Index Fund ETF trades at $157.28. The key difference: Danaher Corporation pays a 0.8% dividend while Vanguard Total World Stock Index Fund ETF pays none, and Vanguard Total World Stock Index Fund ETF is trading nearer its 52-week high, Danaher Corporation nearer its low. Which is the better fit depends on your goals.
| DHR | VT | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $242.05 | $159.35 |
52-Week Low | $161.91 | $128.41 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
VT trades at $155.81, down 1.15% today, with technical indicators showing a neutral to bearish bias. The ETF offers global diversification with over 10,000 holdings and a 1.6% dividend yield, but key valuation metrics like P/E and P/S are unavailable. Recent news highlights comparisons with competing global ETFs, emphasizing VT's broad exposure versus lower-cost alternatives.
Outlook remains balanced; broad diversification supports long-term stability, but expense ratio competition and neutral technical signals suggest limited near-term catalysts. Risks include global market volatility and fee pressure from rivals like SCHF and SPDW.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Vanguard Total World Stock Index Fund ETF
VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →
